Issue of Warrants

Cambridge Cognition Holdings PLC

05 October 2023

 

5 October 2023

Cambridge Cognition Holdings Plc

("Cambridge Cognition", the "Group" or the "Company")

Issue of Warrants

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces, further to the Company's announcement on 26 September 2023, that the Company has issued Claret European Specialty Lending Company III, S.à r.l. ("Claret") with warrants to subscribe for 722,565 new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 74.734p.

Enquiries

Cambridge Cognition Holdings Plc   Matthew Stork, Chief Executive Officer   Stephen Symonds, Chief Financial Officer	Tel: [phone]   [e-mail]
Panmure Gordon (UK) Limited (NOMAD and Joint Broker)   Freddy Crossley / Emma Earl / Mark Rodgers Rupert Dearden	Tel: [phone]   (Corporate Finance)   (Corporate Broking)
Dowgate Capital Limited (Joint Broker)   David Poutney / James Serjeant	Tel: [phone]
IFC Advisory Ltd (Financial PR and IR)   Tim Metcalfe / Graham Herring / Zach Cohen	Tel: [phone]    [e-mail]

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit www.cambridgecognition.com

 

END